Medications

Clinical trial suggests Parkinson's drug is safe in humans

A large team of researchers from Denali Therapeutics, working with colleagues from multiple entities in the U.S. and one in Canada, has found that a LRRK2 inhibitor called DNL201 showed no ill effects to volunteers in a clinical ...

Parkinson's & Movement disorders

New research shows Parkinson's disease origins in the gut

In experiments in mice, Johns Hopkins Medicine researchers say they have found additional evidence that Parkinson's disease originates among cells in the gut and travels up the body's neurons to the brain. The study, described ...

page 2 from 40